Aliases & Classifications for Dysphagia

MalaCards integrated aliases for Dysphagia:

Name: Dysphagia 50 28 51
Deglutition Disorders 69

Classifications:



External Ids:

ICD10 32 R13
UMLS 69 C0011168

Summaries for Dysphagia

NINDS : 50 Having trouble swallowing (dysphagia) is a symptom that accompanies a number of neurological disorders. The problem can occur at any stage of the normal swallowing process as food and liquid move from the mouth, down the back of the throat, through the esophagus and into the stomach. Difficulties can range from a total inability to swallow, to coughing or choking because the food or liquid is entering the windpipe, which is referred to as aspiration. When aspiration is frequent a person can be at risk of developing pneumonia. Food may get "stuck" in the throat or individuals may drool because they cannot swallow their saliva. Neurological conditions that can cause swallowing difficulties are: stroke (the most common cause of dysphagia); traumatic brain injury; cerebral palsy; Parkinson disease and other degenerative neurological disorders such as amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease), multiple sclerosis, progressive supranuclear palsy, Huntington disease, and myasthenia gravis. Muscular dystrophy and myotonic dystrophy are accompanied by dysphagia, which is also the cardinal symptom of oculopharyngeal muscular dystrophy, a rare, progressive genetic disorder.

MalaCards based summary : Dysphagia, also known as deglutition disorders, is related to leigh syndrome and neuromuscular disease, and has symptoms including dysphagia, pharyngoesophageal phase, dysphagia, pharyngeal phase and pseudobulbar signs. An important gene associated with Dysphagia is MEGF10 (Multiple EGF Like Domains 10), and among its related pathways/superpathways is Type II diabetes mellitus. The drugs Dopamine and Pantoprazole have been mentioned in the context of this disorder. Affiliated tissues include testes, lung and tongue.

Wikipedia : 72 Dysphagia is the medical term for the symptom of difficulty in swallowing. Although classified under... more...

Related Diseases for Dysphagia

Diseases related to Dysphagia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 377)
# Related Disease Score Top Affiliating Genes
1 leigh syndrome 30.0 NARS2 SLC19A3 SURF1
2 neuromuscular disease 29.1 DES PABPN1
3 myopathy 28.6 DES MEGF10 PABPN1 PIK3C2A
4 myopathy, areflexia, respiratory distress, and dysphagia, early-onset 12.4
5 odontoma-dysphagia syndrome 12.3
6 dysphagia lusoria 12.3
7 plummer vinson syndrome 11.7
8 oculopharyngeal muscular dystrophy 11.3
9 swallowing disorders 11.3
10 chronic progressive external ophthalmoplegia 11.1
11 jackhammer esophagus 11.1
12 opitz-gbbb syndrome 11.1
13 aspiration pneumonia 11.1
14 esophagitis, eosinophilic, 1 11.1
15 opitz gbbb syndrome, type ii 11.1
16 esophageal tuberculosis 11.0
17 amyotrophic lateral sclerosis 1 11.0
18 myasthenia gravis 11.0
19 aberrant subclavian artery 11.0
20 central pontine myelinolysis 10.9
21 thiamine metabolism dysfunction syndrome 2 10.8
22 striatonigral degeneration, infantile 10.8
23 chromosome 1p36 deletion syndrome 10.8
24 neurodegeneration with brain iron accumulation 3 10.8
25 achalasia, familial esophageal 10.7
26 spinal and bulbar muscular atrophy, x-linked 1 10.7
27 adolescent-onset dystonia of mixed type 10.7
28 x-linked dystonia-parkinsonism/lubag 10.7
29 achalasia-microcephaly syndrome 10.7
30 leber optic atrophy and dystonia 10.7
31 5q31.3 microdeletion syndrome 10.7
32 fazio-londe disease 10.7
33 spastic paralysis, infantile-onset ascending 10.7
34 neurodegeneration with brain iron accumulation 4 10.7
35 cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss 10.7
36 peroxisome biogenesis disorder 8b 10.7
37 scapuloperoneal syndrome, neurogenic, kaeser type 10.7
38 laryngeal tuberculosis 10.7
39 extrapontine myelinolysis 10.7
40 cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss 10.7
41 corticobasal degeneration 10.7
42 diffuse cutaneous systemic sclerosis 10.7
43 thyroglossal duct cyst, familial 10.7
44 wilson disease 10.7
45 spinocerebellar ataxia 13 10.7
46 pontocerebellar hypoplasia, type 2e 10.7
47 pura syndrome 10.7
48 oculopharyngodistal myopathy 10.7
49 biotin-thiamine-responsive basal ganglia disease 10.7
50 mohr-tranebjaerg syndrome 10.7

Graphical network of the top 20 diseases related to Dysphagia:



Diseases related to Dysphagia

Symptoms & Phenotypes for Dysphagia

UMLS symptoms related to Dysphagia:


dysphagia, pharyngoesophageal phase, dysphagia, pharyngeal phase, pseudobulbar signs, symptom as reason for upper g.i. examination, gastrointestinal gas, choking sensation, digestive system symptom, swallowing problems, absent deglutition, pain in esophagus (finding), odynophagia, other symptoms involving digestive system, symptoms involving digestive system, vomiting, signs and symptoms, digestive, seizures, nausea and vomiting, nausea, icterus, heartburn, headache, flatulence, eructation, and gas pain, dyspepsia, diarrhea, constipation, abdominal pain

Drugs & Therapeutics for Dysphagia

Drugs for Dysphagia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 518)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 3 51-61-6, 62-31-7 681
2
Pantoprazole Approved Phase 4,Phase 3,Phase 2,Phase 1 102625-70-7 4679
3
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
4
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
5
Acetylcholine Approved Phase 4,Phase 2 51-84-3 187
6
Cetuximab Approved Phase 4,Phase 3,Phase 2,Phase 1 205923-56-4 56842117 2333
7
Sucralfate Approved Phase 4 54182-58-0 0
8
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 103577-45-3 3883
9
Rabeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 117976-89-3 5029
10
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 161796-78-7, 119141-88-7 9579578 4594
11
Domperidone Approved, Investigational, Vet_approved Phase 4,Phase 3 57808-66-9 3151
12
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3 55-56-1 2713 9552079
13
Menthol Approved Phase 4,Phase 1,Phase 2,Early Phase 1 2216-51-5 16666
14
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3 437-38-7 3345
15
Methylene blue Approved, Investigational Phase 4 61-73-4
16
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 138530-94-6, 103577-45-3 9578005
17
Fluorouracil Approved Phase 4,Phase 3,Phase 2 51-21-8 3385
18
Alginic acid Approved, Experimental, Investigational Phase 4,Phase 3,Phase 1 9005-32-7
19
Ethanol Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 64-17-5 702
20
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
21
Diclofenac Approved, Vet_approved Phase 4,Phase 2,Phase 3 15307-86-5 3033
22
Morphine Approved, Investigational Phase 4 57-27-2 5288826
23
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
24
Rocuronium Approved Phase 4 119302-91-9, 143558-00-3 441290
25
Metoclopramide Approved, Investigational Phase 4,Phase 3 364-62-5 4168
26
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-45-6, 75614-87-8 774
27
Ranitidine Approved Phase 4,Phase 3,Phase 2 66357-59-3, 66357-35-5 3001055
28
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
29
Famotidine Approved Phase 4,Phase 2,Phase 3 76824-35-6 3325
30
Pectin Approved, Vet_approved Phase 4,Phase 3 9000-69-5 441476
31
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 22916-47-8 4189
32
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
33
Remifentanil Approved Phase 4 132875-61-7 60815
34
Bupivacaine Approved, Investigational Phase 4,Phase 2,Phase 3 38396-39-3, 2180-92-9 2474
35
Meloxicam Approved, Vet_approved Phase 4 71125-38-7 54677470 5281106
36
Benzydamine Approved Phase 4 642-72-8, 100-46-9 7504
37
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
38
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
39
Nortriptyline Approved Phase 4,Phase 2,Phase 3 72-69-5 4543
40
Nizatidine Approved Phase 4,Phase 3 76963-41-2 3033637
41
Benzocaine Approved, Investigational Phase 4,Phase 3 1994-09-7, 94-09-7 2337
42
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
43
Levobupivacaine Approved, Investigational Phase 4 27262-47-1 92253
44
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3,Phase 1 21645-51-2
45
Magnesium Hydroxide Approved, Investigational Phase 4,Phase 3,Phase 1 1309-42-8
46 Magnesium trisilicate Approved Phase 4,Phase 3,Phase 1 14987-04-3
47
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-24-8 5755
48
Trimebutine Approved Phase 4 39133-31-8
49
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1 83-43-2 6741
50
Prednisone Approved, Vet_approved Phase 4,Phase 1 53-03-2 5865

Interventional clinical trials:

(show top 50) (show all 1314)

# Name Status NCT ID Phase Drugs
1 Personalized Peroral Endoscopic Myotomy for Achalasia Unknown status NCT01570621 Phase 4
2 Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck Unknown status NCT02015650 Phase 4 Cetuximab;Mitomycin-C/ 5-Fluorouracil
3 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
4 Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity Unknown status NCT02140073 Phase 4 omeprazole+domperidone SR;omeprazole
5 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
6 Development of Applications of the Bravo® pH Monitoring System and Evaluation of Its Performance Unknown status NCT01503476 Phase 4
7 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
8 Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances Unknown status NCT02277886 Phase 4 sodium alginate;esomeprazole
9 Dexlansoprazole to Treat Laryngopharyngeal Reflux and Lingual Tonsil Hypertrophy Unknown status NCT01328652 Phase 4 dexlansoprazole
10 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
11 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
12 Evaluation of Two Different Thickening Products in Patients With Dysphagia Completed NCT01651975 Phase 4
13 Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal Cleft Completed NCT01507207 Phase 4
14 Neuromuscular Electroestimulation and Respiratory Muscle Training in Subacute Stroke Completed NCT02473432 Phase 4
15 Repetitive Transcranial Stimulation (rTMS) in Post Stroke Dysphagia Completed NCT01081444 Phase 4
16 Dysphagia in Elderly Medical Patients Completed NCT01006330 Phase 4
17 Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration Completed NCT01495377 Phase 4 Remifentanil;Placebo;Technetium
18 Peritonsillar Infiltration With Levobupivacaine for Posttonsillectomy Pain Completed NCT02322346 Phase 4 Group LL;Group HL
19 Acetaminophen's Efficacy For Post-operative Pain Completed NCT01721486 Phase 4 IV acetaminophen;PO acetaminophen
20 Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia Completed NCT00528541 Phase 4
21 Ulcer Prevention Study in Post Gastric Bypass Patients Completed NCT00557349 Phase 4 Omeprazole;Famotidine
22 Opioid Effects on Swallowing Comparing Younger and Elderly Volunteers Completed NCT01924234 Phase 4 Morphine;Remifentanil
23 Effect of Laryngeal Mask Cuff Pressure in Geriatric Patients Completed NCT02189954 Phase 4
24 Blind Intubation Through The Self-Pressurised Disposable Air-Q Laryngeal Intubation Mask: An International Multicentre Trial Completed NCT01906060 Phase 4
25 Opioid Effects on Swallowing and Esophageal Sphincter Pressure Completed NCT01191645 Phase 4 naloxone;remifentanil;Sodium Chloride;metoclopramide
26 To Evaluate the Effect of Chlorhexidine-benzidamine Administration Completed NCT03253497 Phase 4 Chlorobenzene Liquid
27 Comparing Hemodynamic Changes for Intubation With Shikani Intubating Stylet and Macintosh Laryngoscope Completed NCT01271543 Phase 4
28 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus (Arm B);Clotrimazole Troche;Tacrolimus (Arm A);Nystatin Suspension
29 Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) Completed NCT00872755 Phase 4
30 Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis Completed NCT03323528 Phase 4 Benzalkonium Chloride-Benzocaine Topical;Placebo Oral Tablet
31 A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Completed NCT00641602 Phase 4 Esomeprazole;Lansoprazole
32 An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) Completed NCT00242736 Phase 4 Esomeprazole
33 Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis Completed NCT02229747 Phase 4 Meloxicam;Diclofenac;Nimesulide
34 The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series Completed NCT02106273 Phase 4
35 Safety and Efficacy of Lansoprazole in Patients With Reflux Disease Completed NCT01135368 Phase 4 Lansoprazole
36 Esophageal Fully Covered Metal Stents in Caustic Strictures Study Completed NCT01899300 Phase 4
37 WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture Completed NCT01699542 Phase 4
38 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
39 A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study Completed NCT02049112 Phase 4
40 Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B Completed NCT03128736 Phase 4 Esomeprazole group;Dexlansoprazole group
41 The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity Completed NCT02958046 Phase 4 Lansoprazole/Domperidone
42 The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity Completed NCT02689999 Phase 4 Dexrabeprazole 10 mg Enteric-Coated Tablets
43 Role of Pepsin Assay in Wheezy Infants Completed NCT02685436 Phase 4 Omeprazole and domperidone
44 Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease Completed NCT02351960 Phase 4 Dexlansoprazole
45 Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease. Completed NCT01601379 Phase 4
46 Practice and Patient Compliance on the PPI (Proton Pump Inhibitors) Treatment of Gastroesophageal Reflux in South Korea Completed NCT01018160 Phase 4 Rabeprazole Sodium
47 A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) Completed NCT00734097 Phase 4 Esomeprazole 40 mg
48 Role of Mosapride in Patients With Gastroesophageal Reflux Disease Completed NCT00729339 Phase 4 mosapride for the first month and placebo for the 2nd month;placebo for the first and mosapride for the second month
49 Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US Completed NCT00660660 Phase 4 Esomeprazole;Placebo
50 Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously Completed NCT00635414 Phase 4 Esomeprazole;Esomeprazole

Search NIH Clinical Center for Dysphagia

Genetic Tests for Dysphagia

Genetic tests related to Dysphagia:

# Genetic test Affiliating Genes
1 Dysphagia 28

Anatomical Context for Dysphagia

MalaCards organs/tissues related to Dysphagia:

38
Testes, Lung, Tongue, Brain, Bone, Thyroid, Colon

Publications for Dysphagia

Articles related to Dysphagia:

(show top 50) (show all 1107)
# Title Authors Year
1
Prevalence and association of oral candidiasis with dysphagia in individuals with acquired brain injury. ( 29182379 )
2018
2
Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia. ( 29196937 )
2018
3
Pediatric laryngeal cleft repair and dysphagia. ( 29287871 )
2018
4
Introducing a Virtual Lesion Model of Dysphagia Resulting from Pharyngeal Sensory Impairment. ( 29402815 )
2018
5
Feeding experiences of nursing aides for residents with dysphagia. ( 29398011 )
2018
6
Diagnostic accuracy of lip force and tongue strength for sarcopenic dysphagia in older inpatients: A cross-sectional observational study. ( 29398338 )
2018
7
Dysphagia in myasthenia gravis: the tip of the Iceberg. ( 29417423 )
2018
8
Systematic dysphagia screening and dietary modifications to reduce stroke-associated pneumonia rates in a stroke-unit. ( 29389984 )
2018
9
One-Year Risk of Pneumonia and Mortality in Patients with Poststroke Dysphagia: A Nationwide Population-Based Study. ( 29395642 )
2018
10
Short-Term Effects of Cold Liquids on the Pharyngeal Swallow in Preterm Infants with Dysphagia: A Pilot Study. ( 29435661 )
2018
11
The surgical management of dysphagia secondary to diffuse idiopathic skeletal hyperostosis. ( 29438856 )
2018
12
Interdisciplinary Telemedicine in the Management of Dysphagia in Head and Neck. ( 29404691 )
2018
13
Creation and Initial Validation of the International Dysphagia Diet Standardisation Initiative Functional Diet Scale. ( 29428348 )
2018
14
Reversible dysphagia secondary to guttural pouch mycosis in a gelding treated medically with voriconazole and surgically with carotid occlusion and esophagostomy. ( 29386677 )
2018
15
Corrigendum: Image of the month: Dysphagia due to injury of the corticobulbar tract following traumatic brain injury. ( 29436459 )
2018
16
Conus medullaris arteriovenous malformation presenting with acute dysphagia and intractable hiccups. ( 29305117 )
2018
17
International consensus (ICON) on assessment of oropharyngeal dysphagia. ( 29396225 )
2018
18
The impact of the difference in O-C2 angle in the development of dysphagia after occipitocervical fusion: a simulation study in normal volunteers combined with a case-control study. ( 29410299 )
2018
19
Dysphagia lusoria: a little-known cause of dysphagia. ( 29368939 )
2018
20
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. ( 29399642 )
2018
21
Dysphagia and associated clinical markers in neurologically intact children with respiratory disease. ( 29393599 )
2018
22
Structural airway abnormalities contribute to dysphagia in children with esophageal atresia and tracheoesophageal fistula. ( 29429770 )
2018
23
Paraneoplastic Dermatomyositis Syndrome Presenting as Dysphagia. ( 28912913 )
2017
24
Clinical characteristics of neurogenic dysphagia in adult patients with Chiari malformation type I. ( 28416844 )
2017
25
Pearly Esophageal Papules: An Innocent Bystander in the Evaluation of Dysphagia. ( 28911948 )
2017
26
Dysphagia severity is related to the amplitude of distal contractile integral in patients with Jackhammer esophagus. ( 29266608 )
2017
27
A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. ( 28467606 )
2017
28
Ability of High-Resolution Manometry to Determine Feeding Method and to Predict Aspiration Pneumonia in Patients With Dysphagia. ( 28374817 )
2017
29
Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. ( 28404653 )
2017
30
Eagle syndrome as an uncommon cause of dysphagia. ( 28533026 )
2017
31
An Unusual Cause of Pediatric Dysphagia: Bronchogenic Cyst. ( 28229098 )
2017
32
Mucinous adenocarcinoma of unknown primary presenting with dysphagia. ( 29223385 )
2017
33
In this issue - July 2017: RHDV vaccine protects against both strains of virus a88A^a88 Olfactory neuroblastoma in a Malamute a88A^a88 Coincidental conditions affecting dysphagia in a Miniature Poodle a88A^a88 Support for storing high-quality bovine colostrum a88A^a88 Sarcoptic mange in koalas a88A^a88 Renal oxalosis in rare Gilbert's potoroos a88A^a88 Novel trypanosomes in a little red flying fox. ( 28653384 )
2017
34
Oropharyngeal dysphagia profiles in individuals with oculopharyngeal muscular dystrophy. ( 29144056 )
2017
35
Efficacy of BoNT-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with Lateral Medullary Syndrome: a case study. ( 28264544 )
2017
36
A Survey of Australian Dysphagia Practice Patterns. ( 28932903 )
2017
37
Dysphagia caused by an inverted papilloma. ( 29237672 )
2017
38
"Dysphagia-Related Quality of Life in Oculopharyngeal Muscular Dystrophy: Psychometric Properties of the SWAL-QOL Instrument. ( 28472864 )
2017
39
Dysphagia in Perry Syndrome: Pharyngeal Pressure in Two Cases. ( 28690533 )
2017
40
Hiatus Hernia as a Cause of Dysphagia. ( 28730506 )
2017
41
A Rare Cause of Dysphagia in Children: Primary Cricopharyngeal Achalasia. ( 28770566 )
2017
42
High nutrition risk is associated with higher risk of dysphagia in advanced age adults newly admitted to hospital. ( 28913929 )
2017
43
Mechanisms underlying reflux symptoms and dysphagia in patients with joint hypermobility syndrome, with and without postural tachycardia syndrome. ( 28191707 )
2017
44
Diffuse Idiopathic Skeletal Hyperostosis Involving Cervical and Lumbar Spine Presenting with Dysphagia: A Case Report. ( 28819624 )
2017
45
Correlations Between Patient-Reported Dysphagia Screening and Penetration-Aspiration Scores in Head and Neck Cancer Patients Post-oncological Treatment. ( 28887707 )
2017
46
Recurrent episodes of esophageal candidiasis without dysphagia post-Guillain-BarrAc syndrome: an unusual presentation of achalasia. ( 29038193 )
2017
47
Dysphagia lusoria presenting as epigastric pain. ( 29212867 )
2017
48
Assessing Dysphagia in Older Adults. ( 28906187 )
2017
49
Botulinum toxin alleviates dysphagia of patients with inclusion body myositis. ( 28870555 )
2017
50
Anti-transcription Intermediary Factor1I^-antibody-positive Dermatomyositis Complicated by Dysphagia. ( 28943591 )
2017

Variations for Dysphagia

Expression for Dysphagia

Search GEO for disease gene expression data for Dysphagia.

Pathways for Dysphagia

Pathways related to Dysphagia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
10.61 PIK3C2A SURF1

GO Terms for Dysphagia

Biological processes related to Dysphagia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 muscle contraction GO:0006936 8.62 DES PABPN1

Sources for Dysphagia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....